These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 8131778)

  • 1. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell granule-mediated uptake of low density lipoproteins by macrophages: a novel carrier mechanism leading to the formation of foam cells.
    Kovanen PT
    Ann Med; 1991; 23(5):551-9. PubMed ID: 1756025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
    Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
    J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis.
    Lindstedt KA; Kokkonen JO; Kovanen PT
    J Lipid Res; 1992 Jan; 33(1):65-75. PubMed ID: 1552234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mast cells in atherosclerosis.
    Kovanen PT
    Chem Immunol; 1995; 62():132-70. PubMed ID: 7546279
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of LDL in mast cells recovering from degranulation. Description of a novel intracellular pathway leading to proteolytic modification of the lipoprotein.
    Kokkonen JO; Lindstedt KA; Kovanen PT
    Arterioscler Thromb; 1993 Feb; 13(2):276-85. PubMed ID: 8427862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs.
    Ma H; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):E134-42. PubMed ID: 11116078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells.
    Decorti G; Klugmann FB; Crivellato E; Malusà N; Furlan G; Candussio L; Giraldi T
    Toxicol Appl Pharmacol; 2000 Dec; 169(3):269-75. PubMed ID: 11133349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of low density lipoproteins by rat serosal mast cells.
    Kokkonen JO; Kovanen PT
    Eur Heart J; 1990 Aug; 11 Suppl E():134-46. PubMed ID: 2226522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell granule remnants carry LDL into smooth muscle cells of the synthetic phenotype and induce their conversion into foam cells.
    Wang Y; Lindstedt KA; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):801-10. PubMed ID: 7773737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
    Paananen K; Kovanen PT
    J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
    Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
    Kaplan M; Aviram M
    Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE-dependent generation of foam cells: an immune mechanism involving degranulation of sensitized mast cells with resultant uptake of LDL by macrophages.
    Ma H; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):811-9. PubMed ID: 7773738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease.
    Kovanen PT
    Heart Vessels; 1997; Suppl 12():125-7. PubMed ID: 9476562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein.
    Kokkonen JO; Kovanen PT
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2287-91. PubMed ID: 3470793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
    Atkins FM; Metcalfe DD
    J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell-mediated inhibition of reverse cholesterol transport.
    Lee M; Lindstedt LK; Kovanen PT
    Arterioscler Thromb; 1992 Nov; 12(11):1329-35. PubMed ID: 1420092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis.
    Seike M; Ikeda M; Matsumoto M; Hamada R; Takeya M; Kodama H
    J Dermatol Sci; 2006 Mar; 41(3):197-204. PubMed ID: 16356687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.